Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

“Blush had a real moment in 2025, with lots of cool girls in Korea wearing blush high up on their cheeks, right below their ...

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ...

Although holidays are associated with joy and fun, for some it is a period of emotional stress and unique problems, including ...

BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...

Many of these firms are leveraging their core expertise to evolve and find new uses for their proprietary technology. Read ...

You can see it in the biggest labor shift in modern history. In the early 1800s, around 70% of Americans worked on farms.

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

Canadians learned how plants make a rare natural substance—mitraphylline—with its potential for fighting cancer as a ...

In my last column, we commenced a discussion on Innovation Funds detailing what businesses it usually invests in and its ...